Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals

Sharada Saraf; Xianming Zhu; Ruchee Shrestha; Tania S. Bonny; Owen R. Baker; Evan J. Beck; Reinaldo E. Fernandez; Yolanda Eby; Olivia Akinde; Jessica E. Ruff; Patrizio Caturegli; Andrew D. Redd; Evan M. Bloch; Thomas C. Quinn; Aaron AR Tobian; Oliver Laeyendecker.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-22270718

Documentos relacionados

  1. Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.
  2. Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.
  3. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.
  4. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
  5. Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19.
  6. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.
  7. Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment.